Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.42
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
12.36
-0.06 (-0.50%)
After-hours: May 22, 2026, 7:40 PM EDT

Amneal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,9623,9642,4541,861301716
Market Cap Growth
69.47%61.50%31.89%517.27%-57.88%6.05%
Enterprise Value
6,4586,3974,7534,5052,9773,313
Last Close Price
12.4212.607.926.071.994.79
PE Ratio
33.4757.27---68.43
Forward PE
10.9315.0411.6911.922.715.65
PEG Ratio
-0.510.510.510.180.66
PS Ratio
1.301.310.880.780.140.34
PB Ratio
99.20-55.99-22.4694.071.011.99
P/TBV Ratio
-87.89-57.81-22.4054.051.012.02
P/FCF Ratio
19.1216.4410.456.2318.493.75
P/OCF Ratio
12.9611.668.325.384.632.96
EV/Sales Ratio
2.122.121.701.881.351.58
EV/EBITDA Ratio
9.6710.369.7910.3920.508.58
EV/EBIT Ratio
14.0016.2319.0722.04-21.69
EV/FCF Ratio
31.1626.5320.2515.08182.6017.35
Debt / Equity Ratio
66.97447.34-52.8344.0713.407.37
Debt / EBITDA Ratio
4.204.355.346.3419.597.45
Debt / FCF Ratio
13.0111.1511.059.21174.5015.07
Net Debt / Equity Ratio
-54.93-33.59-22.65134.049.427.27
Net Debt / EBITDA Ratio
3.893.855.106.1119.356.78
Net Debt / FCF Ratio
12.049.8610.548.87172.3313.72
Asset Turnover
0.840.840.800.660.570.53
Inventory Turnover
2.993.132.972.832.802.70
Quick Ratio
1.451.370.790.841.031.36
Current Ratio
2.472.171.411.631.882.24
Return on Equity (ROE)
789.94%-663.29%-881.26%-36.06%-85.96%5.45%
Return on Assets (ROA)
12.03%10.09%9.60%6.80%-2.52%2.47%
Return on Invested Capital (ROIC)
16.44%13.79%12.21%8.15%-3.05%3.17%
Return on Capital Employed (ROCE)
15.53%15.25%9.98%7.21%-3.01%4.63%
Earnings Yield
3.08%1.75%---1.46%
FCF Yield
5.23%6.08%9.57%16.06%5.41%26.67%
Buyback Yield / Dilution
-5.20%-5.12%-75.42%-16.53%0.41%-1.67%
Total Shareholder Return
-5.20%-5.12%-75.42%-16.53%0.41%-1.67%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q